0001836891-21-000002.txt : 20210622 0001836891-21-000002.hdr.sgml : 20210622 20210622152427 ACCESSION NUMBER: 0001836891-21-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210622 DATE AS OF CHANGE: 20210622 EFFECTIVENESS DATE: 20210622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Angarus Therapeutics, Inc. CENTRAL INDEX KEY: 0001836891 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-384604 FILM NUMBER: 211034669 BUSINESS ADDRESS: STREET 1: 321 DEDALERA DR. CITY: PORTOLA VALLEY STATE: CA ZIP: 94028 BUSINESS PHONE: 650-575-1702 MAIL ADDRESS: STREET 1: 321 DEDALERA DR. CITY: PORTOLA VALLEY STATE: CA ZIP: 94028 D/A 1 primary_doc.xml X0708 D/A LIVE 0001836891 Angarus Therapeutics, Inc. 321 DEDALERA DR. PORTOLA VALLEY CA CALIFORNIA 94028 650-575-1702 DELAWARE None None Corporation true 2018 Nigel Ray c/o Angarus Therapeutics, Inc. 321 Dedalera Dr. Portola Valley CA CALIFORNIA 94028 Executive Officer Director Chih-Ping Liu c/o Angarus Therapeutics, Inc. 321 Dedalera Dr. Portola Valley CA CALIFORNIA 94028 Director Peter Langecker c/o Angarus Therapeutics, Inc. 321 Dedalera Dr. Portola Valley CA CALIFORNIA 94028 Director Jean Liu c/o Angarus Therapeutics, Inc. 321 Dedalera Dr. Portola Valley CA CALIFORNIA 94028 Director Biotechnology Decline to Disclose 06b true 0001836891-21-000001 2020-12-14 false true false 0 CIM SECURITIES, LLC 120852 None None 6898 S. UNIVERSITY BLVD SUITE 270 CENTENNIAL CO COLORADO 80122 AK ALASKA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA KS KANSAS ME MAINE MI MICHIGAN NJ NEW JERSEY NY NEW YORK ND NORTH DAKOTA PA PENNSYLVANIA SC SOUTH CAROLINA TN TENNESSEE TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WI WISCONSIN false 9745976 9745976 0 false 77 456106 true 0 0 false Angarus Therapeutics, Inc. /s/ Nigel Ray Nigel Ray Chief Executive Officer 2021-06-22